The Patent Finder
US

Antidotes for Factor Xa Inhibitors and Methods of Using the Same

US 9,587,233 In force
OverviewFamilyAssignmentsSources & methods

Term ends Sep 26, 2028 · High confidence

Filed Jul 2, 2015 as application 14/790,305 · Granted Mar 7, 2017
Base term, 20 years from filing
Today
20 years from filing
2008 2028
Clock starts
Sep 26, 2008
Term ends
Sep 26, 2028
Granted
Mar 7, 2017
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,109,046, to Sep 26, 2028. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 26, 2008, when application 12/239,651, the earliest non-provisional in its chain, was filed (this one was filed Jul 2, 2015)Sep 26, 2028High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,109,046)resolves to Sep 26, 2028, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 26, 2028High confidence

This family

US 8,153,590In force
Jan 2034
Jan 2034
US 8,268,783In force
Feb 2029
Feb 2029
US 8,455,441In force
no later than Sep 2028
no later than Sep 2028
US 9,109,046In force
Jan 2029
Jan 2029
US 9,062,298In force
no later than Sep 2028
no later than Sep 2028
US 8,889,129In force
no later than Sep 2028
no later than Sep 2028
US 9,388,401In force
Sep 2028
Sep 2028
US 9,587,233this patent
Sep 2028
Sep 2028
8 of 14 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 2, 2015
Reel 35971, frame 427
Sinha, Uma; Lu, Genmin; Conley, Pamela B.Portola Pharmaceuticals, Inc.Assignment of Assignor's Interest
Mar 18, 2019
Reel 48633, frame 673
Portola Pharmaceuticals, Inc.HCR Collateral Management, LLCSecurity Interest
Jul 2, 2020
Reel 53120, frame 925
HCR Collateral Management, LLCPortola Pharmaceuticals, Inc.Release of Security Interest
Jan 7, 2021
Reel 54920, frame 739
Portola Pharmaceuticals, Inc.Portola Pharmaceuticals, LLCChange of Name
Jan 7, 2021
Reel 54921, frame 131
Portola Pharmaceuticals, LLCAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jan 7, 2021
Reel 54922, frame 857
Alexion Pharma International Operations Unlimited CompanyAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jul 21, 2022
Reel 60799, frame 729
Alexion Pharmaceuticals, Inc.Alexion Pharma International Operations Unlimited CompanyAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited